Hurteloup, P <br/><br/>
Phase II trial of esorubicin in advanced renal carcinoma. Clinical Screening Group of the EROTC.  [electronic resource] 

 -  European journal of cancer & clinical oncology  Jun 1989 
 - 995-6 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0277-5379 
<br/><br/><label>Standard No.: </label>10.1016/0277-5379(89)90161-2  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antibiotics, Antineoplastic--therapeutic use<br/>Carcinoma, Renal Cell--drug therapy<br/>Doxorubicin--analogs & derivatives<br/>Drug Evaluation<br/>Female<br/>Humans<br/>Kidney Neoplasms--drug therapy<br/>Male<br/>Middle Aged